Cargando…

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249

Detalles Bibliográficos
Autores principales:	Kazda, Christof M., Ding, Ying, Kelly, Ronan P., Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E., Lewin, Andrew J., Landschulz, William H., Deeg, Mark A., Moller, David E., Hardy, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439412/ https://www.ncbi.nlm.nih.gov/pubmed/28420698 http://dx.doi.org/10.2337/dc17-er06

Ejemplares similares

Erratum. 2016 Presidential Address: Diabetes at 212°—Confronting the Invisible Disease. Diabetes Care 2016;39:1657–1663
por: Schatz, Desmond
Publicado: (2017)

Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2017)

Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2017)

Erratum. George A. Bray, MD: Progress in Obesity—Multidisciplinary Research, Multidimensional Man. Diabetes Care 2016;39:1481–1485
por: Ryan, Donna H., et al.
Publicado: (2017)

Erratum. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). A Randomized Controlled Trial. Diabetes Care 2016;39:24–30
por: Koivusalo, Saila B., et al.
Publicado: (2017)

Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39:808–815
por: Steven, Sarah, et al.
Publicado: (2018)

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–148
por: Mita, Tomoya, et al.
Publicado: (2017)

Erratum. Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Diabetes Care 2016;39:101–109
por: Cummings, Doyle M., et al.
Publicado: (2016)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
por: Mita, Tomoya, et al.
Publicado: (2017)

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980
por: Aroda, Vanita R., et al.
Publicado: (2017)

Erratum. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011. Diabetes Care 2016;39:363–370. Diabetes Care 2017;40:e26
por: Pathak, Ram D., et al.
Publicado: (2017)

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035
por: Rosenstock, Julio, et al.
Publicado: (2017)

Erratum. GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner. Diabetes 2019;68:34–44
por: Zhang, Yanqing, et al.
Publicado: (2020)

Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation
por: Nasu, Risa, et al.
Publicado: (2023)

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
por: Solomon, Sharon D., et al.
Publicado: (2017)

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
por: Weil, E. Jennifer, et al.
Publicado: (2018)

Bélanger S, Tu MM, Rahim MM, et al. Impaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice. Blood. 2012;120(3):592-602.
Publicado: (2013)

Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
Publicado: (2015)

Erratum. Diabetes Care in the Hospital. Sec. 14. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S120–S127
Publicado: (2017)

Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
por: Hampp, Christian, et al.
Publicado: (2020)

Erratum. Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595—2602
por: Skinner, Sarah C., et al.
Publicado: (2019)

B-Cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 2012;61:2893–2905
por: Mariño, E, et al.
Publicado: (2013)

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002—1009
por: Anderson, Barbara J., et al.
Publicado: (2018)

Erratum. Clinical Course of Myocardial Infarction Among Diabetic Patients. Diabetes Care 1980;3:526–529
por: Czyżk, Artur, et al.
Publicado: (2017)

Erratum. Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes. Diabetes 2017;66:2316–2322
por: Johnson, Matthew B., et al.
Publicado: (2018)

Erratum. Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes. Diabetes 2014;63:3835–3845
por: Arif, Sefina, et al.
Publicado: (2015)

Erratum. The virtual office visit for women with gestational diabetes mellitus. Diabetes Care 2017;40:e34—e35
por: Sacks, David A., et al.
Publicado: (2019)

Erratum. Association Between Serum IGF-1 and Diabetes Among U.S. Adults. Diabetes Care 2010;33:2257—2259
por: Teppala, Srinivas, et al.
Publicado: (2017)

Erratum. miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes. Diabetes 2018;67:2554–2568
por: Torella, Daniele, et al.
Publicado: (2020)

Erratum. Association Between Serum IGF-1 and Diabetes Among U.S. Adults. Diabetes Care 2010;33:2257–2259
por: Teppala, Srinivas, et al.
Publicado: (2015)

Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590–1599
por: LeBlanc, Erin S., et al.
Publicado: (2019)

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007;30:1581–1583
Publicado: (2013)

Erratum. Time Trends of Dietary and Lifestyle Factors and Their Potential Impact on Diabetes Burden in China. Diabetes Care 2017;40:1685–1694
por: Li, Yanping, et al.
Publicado: (2018)

Erratum. The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future. Diabetes Care 2018;41:209–218
por: Siminerio, Linda M., et al.
Publicado: (2018)

Erratum. Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults. Diabetes Care 2015;38:e102–e103
por: Alam, Uazman, et al.
Publicado: (2015)

Erratum. Serum 25-Hydroxyvitamin D Levels and Prediabetes Among Subjects Free of Diabetes. Diabetes Care 2011;34:1114–1119
por: Shankar, Anoop, et al.
Publicado: (2015)

Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232
por: Vora, J
Publicado: (2013)

Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361–2369
por: Vaisar, Tomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d03nmgcag8rqbgjquqt9jgjgv5